Halozyme Therapeutics
HALO
#2189
Rank
โ‚ฌ7.80 B
Marketcap
65,81ย โ‚ฌ
Share price
3.20%
Change (1 day)
48.37%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): โ‚ฌ0.40 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are โ‚ฌ1.39 Billion. a decrease over its 2024 earnings that were of โ‚ฌ0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.40 B-16.2%
2024 โ‚ฌ0.48 B59.94%
2023 โ‚ฌ0.30 B39.94%
2022 โ‚ฌ0.21 B0.16%
2021 โ‚ฌ0.21 B92.2%
2020 โ‚ฌ0.11 B-278.96%
2019 -โ‚ฌ63.44 Million-9.45%
2018 -โ‚ฌ70.06 Million-229.51%
2017 โ‚ฌ54.09 M-160.48%
2016 -โ‚ฌ89.44 Million216.03%
2015 -โ‚ฌ28.3 Million-52.86%
2014 -โ‚ฌ60.04 Million-18.09%
2013 -โ‚ฌ73.3 Million55.88%
2012 -โ‚ฌ47.02 Million169.94%
2011 -โ‚ฌ17.42 Million-63.44%
2010 -โ‚ฌ47.64 Million-7.19%
2009 -โ‚ฌ51.33 Million15.91%
2008 -โ‚ฌ44.29 Million83.89%
2007 -โ‚ฌ24.09 Million78.1%
2006 -โ‚ฌ13.53 Million16%
2005 -โ‚ฌ11.66 Million45.24%
2004 -โ‚ฌ8.03 Million682.42%
2003 -โ‚ฌ1.03 Million1659.12%
2002 -โ‚ฌ0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.80 B 5,464.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.29 B 2,168.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ27.32 B 6,566.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.72 B 1,540.37%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚ฌ0.45 Billion-208.81%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ1.23 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA